Smruthi Organics Ltd. engages in the provision of manufacture and sale of bulk drugs and drug intermediates. It operates through the Bulk Drugs and Drugs Intermediates and Formulation segments. Its products include amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. The company was founded by Purushotham Mallayya Eaga on July 11, 1989 and is headquartered in Solapur, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company